11.3 Endocrine Pathologies & Hormonal Imbalances

Endocrine Pathologies & Hormonal Imbalances

Core Concept: When endocrine feedback loops fail, hormonal hypersecretion or hyposecretion alters whole-body homeostasis. Understanding the clinical presentations of diabetes mellitus, thyroid dysfunctions, adrenal syndromes, and pituitary disorders enables practitioners to identify contraindications, modify therapeutic techniques, and recognize emergent metabolic crises.

---

1. Diabetes Mellitus: Types, Pathophysiology & Complications

Diabetes Mellitus (DM) is a chronic metabolic disorder of carbohydrate, lipid, and protein metabolism characterized by persistent hyperglycemia (elevated circulating blood glucose). It arises from defects in insulin secretion, insulin action, or both. In healthy individuals, fasting blood glucose is maintained between 4.0 and 7.0 mmol/L (~72–126 mg/dL). Diagnostic thresholds for diabetes include a fasting plasma glucose $\ge 7.0\text{ mmol/L}$ ($\ge 126\text{ mg/dL}$) or a glycated hemoglobin ($HbA1c$) level $\ge 6.5%$ ($\ge 48\text{ mmol/mol}$).

Type 1 vs. Type 2 Diabetes Mellitus

The Classic Diagnostic Triad: The "Three Ps"

Regardless of etiology, severe hyperglycemia produces three hallmark clinical manifestations:

1. Polyuria (Excessive Urination): When arterial blood glucose exceeds the renal transport threshold (~10.0 mmol/L or ~180 mg/dL), glomerular filtration overwhelms the saturable $Na^+$-glucose symporters (SGLT2/SGLT1) in the proximal convoluted tubules. Unabsorbed glucose remains in the tubular lumen, exerting a powerful osmotic diuretic effect that prevents water reabsorption. Massive volumes of water and electrolytes are lost in urine (glucosuria and polyuria).
2. Polydipsia (Excessive Thirst): Unchecked osmotic fluid loss produces severe intracellular and extracellular dehydration. Rising plasma osmolarity directly stimulates osmoreceptors in the hypothalamus, activating the thirst center and driving compulsive, intense fluid consumption.
3. Polyphagia (Excessive Hunger): Despite high concentrations of extracellular glucose, the absence of effective insulin prevents glucose from entering skeletal muscle and adipose cells. Starving intracellular tissues send starvation signals to hypothalamic hunger centers, stimulating ravenous appetite. Because cells cannot utilize carbohydrates, the body catabolizes skeletal muscle proteins and adipose triglycerides, causing progressive weight loss and physical fatigue despite polyphagia.

Acute Life-Threatening Hyperglycemic Crises

• Diabetic Ketoacidosis (DKA): Occurs primarily in Type 1 diabetes when insulin levels are completely inadequate. Without insulin, uncontrolled lipolysis floods the liver with free fatty acids. Hepatic beta-oxidation converts fatty acids into acidic ketone bodies (acetoacetate and $\beta$-hydroxybutyrate). Ketone accumulation overwhelms bicarbonate buffers, producing severe metabolic acidosis (arterial $\text{pH} < 7.30$). Patients present with nausea, vomiting, abdominal pain, profound dehydration, an acetone "fruity" odor on the breath, and deep, rapid, labored respirations (Kussmaul breathing) as the respiratory system attempts to blow off carbon dioxide to compensate for metabolic acidosis.
• Hyperosmolar Hyperglycemic State (HHS): Occurs primarily in Type 2 diabetes. Severe, sustained hyperglycemia (frequently $>33.3\text{ mmol/L}$ or $>600\text{ mg/dL}$) causes massive osmotic diuresis, profound dehydration, and extreme serum hyperosmolarity ($>320\text{ mOsm/kg}$). Because traces of endogenous insulin remain, adipose lipolysis is sufficiently restrained to prevent significant ketoacidosis, but profound neurological deficits, lethargy, seizures, and coma develop.

Chronic Long-Term Vascular & Neurological Complications

Chronic, unmanaged hyperglycemia induces widespread non-enzymatic glycosylation of vascular proteins, endothelial injury, and sorbitol accumulation:

1. Microvascular Complications (Damage to Small Capillaries):
   • Diabetic Retinopathy: Microaneurysms, retinal hemorrhages, hard exudates, and neo-vascularization leading to retinal detachment and blindness.
   • Diabetic Nephropathy: Glomerular basement membrane thickening and nodular glomerulosclerosis (Kimmelstiel-Wilson lesions), manifesting initially as microalbuminuria and progressing to end-stage renal disease (ESRD).
   • Diabetic Neuropathy: Chronic ischemic damage to vasa nervorum and sorbitol-induced axonal degeneration:
     • Peripheral Sensory Neuropathy: Bilateral, symmetrical, "glove-and-stocking" distribution of paresthesias (tingling, burning sensations), hyperalgesia, and eventual complete loss of protective pain and temperature sensation in feet and lower legs.
     • Autonomic Neuropathy: Gastroparesis, resting tachycardia, orthostatic hypotension, neurogenic bladder, and erectile dysfunction.
2. Macrovascular Complications (Accelerated Atherosclerosis in Large Arteries):
   • Coronary Artery Disease (CAD): Angina and myocardial infarction (frequently painless or "silent" due to autonomic sensory denervation).
   • Cerebrovascular Disease: Transient ischemic attacks (TIAs) and ischemic strokes.
   • Peripheral Arterial Disease (PAD): Arterial insufficiency in lower extremities, intermittent claudication, poor peripheral tissue perfusion, and impaired wound healing.
   • The Diabetic Foot: The catastrophic confluence of peripheral sensory neuropathy (unnoticed microtrauma, blisters, or foreign objects in shoes), peripheral arterial disease (inadequate perfusion for tissue healing), and hyperglycemic immunosuppression. Minor cutaneous abrasions rapidly ulcerate, become infected with polymicrobial pathogens, progress to deep gangrene, and necessitate non-traumatic lower-limb amputation.

---

2. Acute Hypoglycemia ("Insulin Shock") & The "Rule of 15"

Hypoglycemia is defined as an acute drop in blood glucose below 4.0 mmol/L (70 mg/dL). It is the most frequent acute medical emergency encountered in diabetic clients receiving insulin or sulfonylurea therapy. It results from a mismatch between insulin availability and metabolic demand (e.g., accidental insulin overdose, delayed or missed meals, unaccustomed physical exertion, or alcohol consumption).

Signs & Symptoms of Hypoglycemia

Symptoms manifest in two successive neurological phases:

• Autonomic / Sympathoadrenal Signs (Early Response): Triggered by compensatory catecholamine release (adrenaline and noradrenaline) as the body attempts to raise blood glucose: profuse cold diaphoresis (sweating), tremors/shakiness, tachycardia, palpitations, pallor, anxiety, restlessness, and intense hunger.
• Neuroglycopenic Signs (Late Response): The central nervous system depends almost entirely on continuous blood glucose delivery for fuel. Glucose deprivation causes: lightheadedness, dizziness, headache, slurred speech, blurred or double vision, cognitive confusion, profound irritability or combativeness, uncoordinated motor movements, and if untreated, progression to epileptic seizures, loss of consciousness, and permanent brain damage.

Emergency Protocol: The "Rule of 15"

When a conscious client displays symptoms of hypoglycemia and has a confirmed or suspected blood glucose $<4.0\text{ mmol/L}$:

1. Administer 15 to 20 grams of fast-acting simple carbohydrates:
   • 150–200 mL (approx. half a glass) of unsweetened fruit juice or regular (non-diet) soda
   • 3 to 4 commercial glucose tablets
   • 4 to 5 jelly babies or sugar candies
   • 3 teaspoons of granulated sugar dissolved in water
2. Rest quietly for 15 minutes and re-evaluate symptoms (and recheck blood glucose with a glucometer if available).
3. If blood glucose remains $<4.0\text{ mmol/L}$ or symptoms persist: Administer a second dose of 15 grams of fast-acting carbohydrate and wait another 15 minutes.
4. Once blood glucose rises $\ge 4.0\text{ mmol/L}$ and symptoms resolve: Provide a snack containing complex carbohydrates and protein (e.g., a slice of wholemeal bread, crackers with cheese, or a glass of milk) to prevent rebound hypoglycemia.
5. Unconscious Client Protocol: If the client loses consciousness or is unable to swallow safely, NEVER attempt to administer oral liquids or foods (severe aspiration hazard). Place the client in the lateral recovery position, immediately summon emergency medical services (999/911/112), and administer intramuscular glucagon if qualified and prescribed.

---

3. Thyroid Disorders: Hypothyroidism vs. Hyperthyroidism

Thyroid disorders reflect extremes in basal metabolic control, presenting polar opposite clinical signs:

Hypothyroidism (Underactive Thyroid)

• Etiology: The most prevalent cause in developed nations is Hashimoto's Thyroiditis (Chronic Autoimmune Thyroiditis), characterized by autoantibodies against thyroid peroxidase (anti-TPO) and thyroglobulin, leading to progressive lymphocytic destruction of follicular architecture. Globally, nutritional endemic iodine deficiency remains a common cause, preventing $T_3/T_4$ synthesis and causing compensatory TSH hypersecretion that produces an enlarged goitre. Other causes include iatrogenic destruction (radioactive iodine ablation, thyroidectomy) and congenital thyroid dysgenesis (cretinism, producing profound irreversible intellectual disability, stunted skeletal growth, and infantile myxedema if not treated at birth).
• Pathophysiology & Presentation: Generalized slowing of cellular metabolism and reduced oxygen consumption:
  • Low basal metabolic rate (BMR), extreme chronic fatigue, physical lethargy, and mental sluggishness.
  • Cold intolerance: Impaired calorigenic heat production; clients feel perpetually chilled.
  • Unintentional weight gain despite reduced appetite; constipation from diminished intestinal peristalsis.
  • Cardiovascular depression: bradycardia ($<60\text{ bpm}$), weak cardiac contractility, and hypotension.
  • Cutaneous manifestations: dry, coarse, pale skin, brittle nails, thinning hair, and lateral eyebrow loss (Queen Anne's sign).
  • Myxedema: Dermal fibroblasts accumulate hydrophilic glycosaminoglycans (chondroitin sulfate and hyaluronic acid) within the interstitial matrix, drawing in water. This produces characteristic non-pitting periorbital edema, facial puffiness, a swollen tongue causing hoarse speech, and non-pitting pretibial swelling. Severe, unmanaged cases can collapse into fatal myxedema coma.
• Diagnostic Laboratory Profile: Elevated serum TSH with low free $T_4$ and free $T_3$ (primary hypothyroidism).

Hyperthyroidism & Thyrotoxicosis (Overactive Thyroid)

• Etiology: The most common cause is Graves' Disease, an autoimmune disorder characterized by circulating Thyroid-Stimulating Immunoglobulins (TSI). These IgG antibodies bind directly to and activate TSH receptors on thyroid follicular cells, bypassing normal negative feedback and driving chronic, uncontrolled $T_3$ and $T_4$ hypersecretion. Other causes include toxic multinodular goitre (Plummer's disease) and toxic adenomas.
• Pathophysiology & Presentation: Excessive cellular metabolic acceleration and heightened sympathetic tone:
  • High basal metabolic rate (BMR), restlessness, motor agitation, insomnia, and emotional lability.
  • Heat intolerance: Excessive thermogenesis; clients experience profuse warm sweating (diaphoresis) and warm, flushed skin.
  • Weight loss despite voracious, increased appetite (hyperphagia); frequent loose bowel movements or diarrhea.
  • Cardiovascular hyperactivation: resting tachycardia ($>100\text{ bpm}$), palpitations, bounding pulse, elevated systolic blood pressure, and risk of atrial fibrillation.
  • Fine postural tremors of the outstretched hands and tongue.
  • Exophthalmos (Proptosis): Unique to Graves' disease. TSI antibodies cross-react with orbital fibroblasts and adipocytes, triggering retro-orbital inflammation, accumulation of hydrophilic glycosaminoglycans, and fluid retention. The expanding retrobulbar tissue pushes the eyeballs forward, producing a characteristic bulging, staring gaze, corneal drying, and diplopia (double vision).
  • Goitre: Diffuse, smooth, hypervascular enlargement of the thyroid gland, often exhibiting a palpable vascular thrill or audible systolic bruit.
• Diagnostic Laboratory Profile: Suppressed/undetectable serum TSH with markedly elevated free $T_4$ and free $T_3$.

---

4. Adrenal Cortex Disorders: Cushing's Syndrome vs. Addison's Disease

Adrenal cortical disorders illustrate the physiological impact of glucocorticoid and mineralocorticoid excess versus deficiency:

Cushing's Syndrome (Hypercortisolemia)

Cushing's syndrome is the clinical state produced by prolonged, abnormal exposure to high circulating levels of cortisol (glucocorticoids):

• Etiology:
  • Iatrogenic / Exogenous (Most Common): Chronic therapeutic administration of pharmacological corticosteroids (e.g., prednisone, dexamethasone) for asthma, rheumatoid arthritis, organ transplantation, or eczema.
  • Endogenous ACTH-Dependent (Cushing's Disease): A benign ACTH-secreting pituitary adenoma (~70% of endogenous cases) that drives bilateral adrenal hyperplasia.
  • Endogenous ACTH-Independent: Autonomous primary cortisol-secreting adrenal adenomas or carcinomas, or ectopic ACTH secretion (e.g., small cell lung carcinoma).
• Hallmark Clinical Features:
  • Adipose Redistribution: "Moon face" (rounded, plethoric facial adiposity), "Buffalo hump" (dorsocervical fat pad accumulation), supraclavicular fat pads, and centripetal/truncal obesity accompanied by thin, wasted extremities.
  • Protein Catabolism & Connective Tissue Fragility: Cortisol degrades structural collagen and matrix proteins. The dermis thins dramatically, leading to fragile, paper-thin skin, easy capillary bruising (ecchymosis) from minor touch, and poor wound healing. Severe dermal tearing under mechanical stretching produces broad, prominent, violaceous (purple) striae across the abdomen, thighs, and breasts.
  • Musculoskeletal: Proximal muscle wasting and severe weakness (cortisol-induced myopathy); osteoporosis and pathological fractures due to osteoblast suppression and decreased intestinal calcium absorption.
  • Metabolic & Vascular: "Adrenal diabetes" (steroid-induced hyperglycemia and insulin resistance), secondary arterial hypertension (mineralocorticoid cross-talk and enhanced vascular responsiveness to catecholamines), and susceptibility to severe opportunistic infections due to chronic immunosuppression.

Addison's Disease (Primary Adrenal Insufficiency)

Addison's disease is a rare, life-threatening disorder caused by progressive, bilateral destruction of the adrenal cortex, resulting in deficient secretion of both glucocorticoids (cortisol) and mineralocorticoids (aldosterone):

• Etiology: In developed countries, ~80% of cases stem from autoimmune adrenalitis (autoantibodies against 21-hydroxylase enzyme). Infectious destruction via tuberculosis, fungal disease, or bilateral adrenal hemorrhage accounts for the remainder.
• Hallmark Clinical Features:
  • Aldosterone Deficiency: Loss of aldosterone causes unchecked renal sodium wasting and potassium retention. Patients experience hypovolemia, chronic dehydration, severe postural / orthostatic hypotension, dizziness, syncope, intense salt craving, hyponatremia, and hyperkalemia (which can trigger lethal cardiac arrhythmias).
  • Cortisol Deficiency: Inability to maintain blood glucose during fasting produces chronic hypoglycemia, profound physical exhaustion, muscular weakness, anorexia, nausea, vomiting, diarrhea, and marked weight loss.
  • Hyperpigmentation ("Skin Bronzing"): Loss of negative feedback by cortisol triggers massive compensatory hypothalamic CRH and anterior pituitary ACTH hypersecretion. The prohormone pro-opiomelanocortin (POMC) is cleaved into ACTH and melanocyte-stimulating hormone (MSH). High circulating ACTH directly binds to and activates melanocortin-1 receptors (MC1R) on cutaneous melanocytes, stimulating excess melanin synthesis. Hyperpigmentation manifests as a striking "bronzed" tan appearance, especially prominent over sun-exposed areas, pressure points (elbows, knees, knuckles), palmar skin creases, surgical scars, and the buccal oral mucosa.
  • Addisonian Crisis (Acute Adrenal Crisis): A catastrophic medical emergency precipitated when an Addisonian patient encounters acute physiological stress (infection, trauma, surgery, or sudden withdrawal of corticosteroid medication). Characterized by intractable vomiting, severe abdominal/flank pain, profound vascular collapse, hypovolemic shock, coma, and death if not treated immediately with intravenous hydrocortisone and isotonic saline.

---

5. Pituitary Growth Hormone (GH) Disorders

Abnormal secretion of human growth hormone (GH / somatotropin) by somatotroph cells of the anterior pituitary produces distinct clinical entities depending upon whether the imbalance occurs prior to or following epiphyseal growth plate closure:

1. Pituitary Gigantism (Childhood GH Hypersecretion):
   • Onset: Occurs in children before the closure of epiphyseal growth plates in long bones, almost universally caused by a benign somatotroph adenoma.
   • Features: Longitudinal bone growth continues unabated, producing extraordinary tall stature (heights often reaching 2.1 to 2.7 meters / 7 to 9 feet) with relatively normal body proportions. Accompanied by generalized organomegaly, cardiomegaly, delayed sexual maturation, and severe joint arthropathy from excessive mechanical skeletal loading.
2. Acromegaly (Adult GH Hypersecretion):
   • Onset: Occurs in adults after the fusion of epiphyseal growth plates (typically diagnosed between ages 30 and 50), caused by a pituitary somatotroph adenoma.
   • Features: Long bones cannot lengthen, so GH and IGF-1 stimulate appositional bone growth (widening and thickening) and soft tissue hypertrophy:
     • Craniofacial Changes: Pronounced enlargement of the cranium and supraorbital ridges; broadening of the nose; thickening of lips; macroglossia (enlarged tongue causing obstructive sleep apnea); and anterior protrusion of the mandible (prognathism), resulting in teeth spacing and bite malocclusion.
     • Extremities: Spadegrowth and widening of hands and feet (clients report increasing shoe, glove, or ring sizes).
     • Systemic & Neurological: Deep, resonant voice from laryngeal cartilage hypertrophy; thick, oily skin with excessive perspiration; peripheral nerve entrapments (especially carpal tunnel syndrome from median nerve compression under the hypertrophied flexor retinaculum); and cardiomegaly, accelerating hypertension, heart failure, and diabetes mellitus (due to GH anti-insulin effects).
3. Pituitary Dwarfism (Growth Hormone Deficiency):
   • Onset: Congenital or early childhood deficiency of GH or lack of tissue responsiveness to IGF-1.
   • Features: Severe proportionate short stature (adult height typically under 1.2 meters / 4 feet). Skeletal proportions, facial features, and intellectual development remain normal (in sharp contrast to the disproportionate limbs and intellectual disability characteristic of untreated congenital cretinism / hypothyroidism).

---

6. Clinical Practice Adaptations & Therapist Guidelines

Practitioners of complementary therapy, bodywork, and aesthetics must adapt treatments for clients with endocrine conditions to ensure safety:

Clinical Adaptations for Diabetes Mellitus

• Insulin Injection & Infusion Sites: Never perform deep friction, vigorous petrissage, or apply local heat over recent subcutaneous insulin injection sites or continuous glucose monitor / pump infusion sites (minimum 2- to 4-hour window). Vigorous massage markedly accelerates local microvascular perfusion, causing rapid subcutaneous insulin absorption that can trigger precipitous, life-threatening hypoglycemia.
• Sensory Neuropathy & Pressure Limits: Clients with peripheral neuropathy cannot accurately gauge mechanical pressure or thermal sensations. Deep tissue work, aggressive trigger-point therapy, and vigorous neuromuscular techniques are contraindicated on the lower legs and feet. Always verify pressure visually and verbally, and maintain broad, light-to-moderate strokes.
• Diabetic Foot Care: Inspect the client's lower extremities before treatment. Never perform aggressive exfoliation, sharp cuticle trimming, or hot foot baths on diabetic feet. Minor micro-cuts can rapidly evolve into refractory, infected diabetic ulcers.
• Treatment Readiness: Confirm that the client has eaten a balanced meal and taken medication normally prior to treatment. Ensure fast-acting oral glucose (fruit juice, glucose tablets) is immediately available in the treatment room.

Clinical Adaptations for Thyroid Imbalances

• Hypothyroidism: Clients experience cold intolerance, sluggish peripheral circulation, and dry skin. Pre-warm the treatment room, provide heated treatment couches and extra blankets, and use rich emollient massage mediums. Tissues affected by myxedema are waterlogged and fragile; vigorous kneading is contraindicated, whereas gentle manual lymphatic drainage can support comfort.
• Hyperthyroidism: Clients are heat intolerant, agitated, and tachycardic. Ensure the treatment room is well-ventilated and cool. Stimulating techniques (rapid tapotement, vigorous friction, contrast hydrotherapy) are contraindicated because they exacerbate sympathetic overload and cardiovascular strain. Strictly avoid applying local mechanical pressure over an enlarged goitre or anterior neck.

Clinical Adaptations for Adrenal Imbalances

• Cushing's Syndrome: Extreme tissue fragility is the primary concern. Dermal thinning and capillary fragility mean that even moderate pressure can cause extensive cutaneous bruising (ecchymosis) or skin tears. Cupping therapy, vigorous friction, and aggressive myofascial release are strictly contraindicated. In addition, severe osteoporosis requires avoiding forceful spinal mobilization or heavy pressure over ribs.
• Addison's Disease: Chronic orthostatic hypotension creates high risk of post-treatment syncope. Avoid rapid position changes; allow the client to transition slowly from prone to supine, sit upright on the couch for several minutes, and verify stability before standing. Clients suffer from profound fatigue; sessions should be gentle, restorative, and of moderate duration.

General Endocrine Contraindications

• Absolute Contraindications (No Treatment Permitted): Acute diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state (HHS), acute severe hypoglycemia, untreated thyrotoxic crisis (thyroid storm), myxedema coma, Addisonian crisis, and open infected diabetic ulcers.

Clinical Trap: Do not confuse Gigantism with Acromegaly! Both result from growth hormone (GH) hypersecretion, but Gigantism occurs in childhood before epiphyseal plate fusion, causing excessive longitudinal height. Acromegaly occurs in adulthood after epiphyseal plates have fused, causing lateral, appositional bone thickening, pronounced jaw protrusion (prognathism), and enlarged spade-like hands and feet.

Diabetes Insipidus

Diabetes insipidus is distinct from diabetes mellitus. In central diabetes insipidus, too little ADH is released; in nephrogenic diabetes insipidus, the kidneys respond poorly to ADH. Collecting ducts cannot conserve water effectively, producing marked polyuria with very dilute urine and compensatory thirst. Blood glucose is not the defining problem. This disorder belongs to both the endocrine and urinary taught-content lists.